335 related articles for article (PubMed ID: 31637449)
1. The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.
Jiang Q; Li F; Cheng Z; Kong Y; Chen C
Cell Mol Life Sci; 2020 Apr; 77(8):1483-1495. PubMed ID: 31637449
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara.
Yu J; Lan J; Zhu Y; Li X; Lai X; Xue Y; Jin C; Huang H
Biochem Biophys Res Commun; 2008 Mar; 367(4):805-12. PubMed ID: 18194665
[TBL] [Abstract][Full Text] [Related]
4. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
Uchida C; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
[TBL] [Abstract][Full Text] [Related]
5. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
6. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8.
Li Y; Kong Y; Zhou Z; Chen H; Wang Z; Hsieh YC; Zhao D; Zhi X; Huang J; Zhang J; Li H; Chen C
Cell Death Dis; 2013 Nov; 4(11):e935. PubMed ID: 24287696
[TBL] [Abstract][Full Text] [Related]
7. The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1.
Li Y; Chen X; Wang Z; Zhao D; Chen H; Chen W; Zhou Z; Zhang J; Zhang J; Li H; Chen C
Neoplasia; 2013 Jan; 15(1):39-48. PubMed ID: 23358872
[TBL] [Abstract][Full Text] [Related]
8. Targeted modulation of E3 ligases using engineered ubiquitin variants.
LeBlanc N; Mallette E; Zhang W
FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
[TBL] [Abstract][Full Text] [Related]
9. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
10. HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway.
Zhang G; Tan R; Wan S; Yang R; Hu X; Zhao E; Ding X; Zhang J; Li B; Liang P; Cui H
Br J Cancer; 2022 Nov; 127(11):1925-1938. PubMed ID: 36088509
[TBL] [Abstract][Full Text] [Related]
11. Interaction between syntaxin 8 and HECTd3, a HECT domain ligase.
Zhang L; Kang L; Bond W; Zhang N
Cell Mol Neurobiol; 2009 Feb; 29(1):115-21. PubMed ID: 18821010
[TBL] [Abstract][Full Text] [Related]
12. E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders.
Saravanan KM; Kannan M; Meera P; Bharathkumar N; Anand T
Future Med Chem; 2022 Jan; 14(3):187-201. PubMed ID: 35100004
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligases in cancer and implications for therapies.
Wang D; Ma L; Wang B; Liu J; Wei W
Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy.
Liu Q; Aminu B; Roscow O; Zhang W
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466790
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase TRIM31: A potential therapeutic target.
Deng NH; Tian Z; Zou YJ; Quan SB
Biomed Pharmacother; 2024 Jul; 176():116846. PubMed ID: 38850648
[TBL] [Abstract][Full Text] [Related]
16. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
Huang F; Huang Z; Wei Q; Liu G; Pu J
Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
[TBL] [Abstract][Full Text] [Related]
17. Targeting HECT-type E3 ligases - insights from catalysis, regulation and inhibitors.
Fajner V; Maspero E; Polo S
FEBS Lett; 2017 Sep; 591(17):2636-2647. PubMed ID: 28771691
[TBL] [Abstract][Full Text] [Related]
18. NEDD4: a promising target for cancer therapy.
Ye X; Wang L; Shang B; Wang Z; Wei W
Curr Cancer Drug Targets; 2014; 14(6):549-56. PubMed ID: 25088038
[TBL] [Abstract][Full Text] [Related]
19. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
20. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
Daks AA; Melino D; Barlev NA
Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
